Home  

Enter a class name or drug name above to search the database.

Decreased IgE Activity [PE]

NDC Number Brand Name Generic Name Labeler Dosage Form DEA Schedule Marketing Start Date
50242-040 XOLAIR omalizumab Genentech, Inc. INJECTION, SOLUTION 2003-06-20
50242-214 Xolair PFS omalizumab Genentech, Inc. INJECTION, SOLUTION 2018-09-28
50242-215 Xolair PFS omalizumab Genentech, Inc. INJECTION, SOLUTION 2018-09-28
50242-227 Xolair omalizumab Genentech, Inc. INJECTION, SOLUTION 2023-08-18

 Physiological Effect (PE) Classification 

Loading full table content...